home · filing · 0001493152-23-018910
8-K
filed May 24, 2023, 7:59 PM ET
CIK 0001839133
leadership
confidence high
sentiment neutral
materiality 0.60
CEO Moshe Gerber resigns; Chairperson Oded Bashan named Interim CEO
IR-Med, Inc.
Moshe Gerber resigned as CEO of IR-Med, Inc. and its Israeli subsidiary, effective May 21, 2023.
Resignation is not due to any disagreement with the company or its auditors.
Gerber will remain available until August 19, 2023, receiving salary and benefits through August.
Accelerated vesting of 433,333 stock options at $0.32/share, exercisable through Dec 31, 2030.
Upon compliance, Gerber receives an additional 21,000 NIS (~$5,780) at end of notice period.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Departed
Moshe Gerber
Chief Executive Officer
IR-Med, Inc.
Effective 2023-05-21
Successor Oded Bashan
Filed May 24, 2023, 7:59 PM ET
pursuant to which MG resigned from his role as Chief Executive Officer of the Companies.
Effective 2023-05-21
Filed May 24, 2023, 7:59 PM ET
Mr. Oded Bashan, the Chairperson and a co-founder of the Company, was appointed as Interim Chief Executive Officer of the Company.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Moshe Gerber resigned as Chief Executive Officer at IR-Med, Inc..
Action resigned
Role Chief Executive Officer
Exact text from the filing
pursuant to which MG resigned from his role as Chief Executive Officer of the Companies.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Oded Bashan was appointed as Interim Chief Executive Officer at IR-Med, Inc..
Action appointed
Role Interim Chief Executive Officer
Exact text from the filing
Mr. Oded Bashan, the Chairperson and a co-founder of the Company, was appointed as Interim Chief Executive Officer of the Company.
View on SEC.gov
Source: SEC EDGAR
accession 0001493152-23-018910
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.